In a new position paper published in today’s edition of the Weekly Epidemiological Record, WHO recommends that countries should consider introduction of the dengue vaccine CYD-TDV or Dengvaxia® only in geographic settings where epidemiological data indicate a high burden of disease.
New data on global immunization coverage show that 86% of the world’s children received 3 doses of diphtheria-tetanus-pertussis (DTP3) vaccines in 2015, a coverage level that has been sustained above 85% since 2010.
The number of children who did not receive routine vaccinations dropped to an estimated 19.4 million, down from 33.8 million in 2000.
The WHO Strategic Advisory Group of Experts on Immunization (SAGE) found that one fifth of the regular dose of yellow fever vaccine could be used to control an outbreak in case of vaccine shortages. In the current yellow fever outbreak, almost 18 million doses of yellow fever vaccine have been distributed in emergency vaccination campaigns in Angola, Democratic Republic of the Congo, and Uganda.
A special issue of the journal Vaccine, guest-edited by WHO and published today, focuses on the research and development pipeline of vaccines against 25 pathogens for which no licensed vaccines currently exists but for which there is high public health importance, as identified by the WHO Product Development for Vaccines Advisory Committee (PDVAC).